A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry
A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry (DEXA) scanners,such as Lunar and Hologic. Merck last month announced financingagreements with the companies to help promote sales of bone densitometrydevices (SCAN 7/6/95).
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.